Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
05/05/2026 02:22
May 5 (Reuters) - Nova Eye Medical Ltd EYE.AX: UPGRADES FY26 SALES GUIDANCE (EX-CHINA) TO U$22–23 MILLION LAST TWELVE-MONTH SALES (EX-CHINA) $21.6 MILLION AT 30 APRIL 2026 Further company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment